Junctophilin-2 expression silencing causes cardiocyte hypertrophy and abnormal intracellular calcium-handling.
Junctophilin-2 expression silencing causes cardiocyte hypertrophy and abnormal intracellular calcium-handling.
复制标题
DOI:
10.1161/circheartfailure.110.958694
复制
发表时间:
2011-03
期刊:
影响因子:
--
通讯作者:
Ackerman MJ
中科院分区:
文献类型:
--
作者:
Landstrom AP;Kellen CA;Dixit SS;van Oort RJ;Garbino A;Weisleder N;Ma J;Wehrens XH;Ackerman MJ
Junctophilin-2 (JPH2), a protein expressed in the junctional membrane complex, is necessary for proper intracellular calcium (Ca2+) signaling in cardiac myocytes. Down-regulation of JPH2 expression in a model of cardiac hypertrophy was recently associated with defective coupling between plasmalemmal L-type Ca2+ channels and sarcoplasmic reticular ryanodine receptors. However, it remains unclear whether JPH2 expression is altered in patients with hypertrophic cardiomyopathy (HCM). In addition, the effects of down-regulation of JPH2 expression on intracellular Ca2+-handling are presently poorly understood. We sought to determine whether loss of JPH2 expression is noted among patients with HCM and whether expression silencing might perturb Ca2+-handling in a pro-hypertrophic manner. JPH2 expression was reduced in flash frozen human cardiac tissue procured from patients with HCM compared to ostensibly healthy traumatic death victims. Partial silencing of JPH2 expression in HL-1 cells by a small interfering RNA probe targeted to murine JPH2 mRNA (shJPH2) resulted in myocyte hypertrophy and increased expression of known markers of cardiac hypertrophy. While expression levels of major Ca2+-handling proteins were unchanged, shJPH2 cells demonstrated depressed maximal Ca2+ transient amplitudes that were insensitive to LTCC activation with JPH2 knock-down. Further, reduced caffeine-triggered SR store Ca2+ levels were observed with potentially increased total Ca2+ stores. Spontaneous Ca2+ oscillations were elicited at a higher extracellular [Ca2+] and with decreased frequency in JPH2 knock-down cells. Our results show that JPH2 levels are reduced in patients with HCM. Reduced JPH2 expression results in reduced excitation-contraction coupling gain as well as altered Ca2+ homeostasis which may be associated with pro-hypertrophic remodeling.